You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
Developing Nanopieces, a Platform RNAi Delivery Technology for Treatment of Multiple Diseases
SBC: Nanode Therapeutics, Inc. Topic: NCATSSTTR_Developing Nanopieces 7. Project Summary/Abstract The bottleneck of developing new RNAi (RNA Interference) drugs is the lack of highly efficient and non-toxic RNA delivery to non-liver tissues in vivo. It is especially challenging to deliver negatively-charged nucleic acid into avascular, dense, and negatively-charged matrix in hard-to-reach tissues including joint cartilage. NanoDe Therapeut ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy
SBC: STRYKAGEN CORPORATION Topic: ODAbstract Duchenne Muscular Dystrophy (DMD) is a fatal muscle disease with a predicted incidence of 1 in 5000 males. DMD results from mutations in the gene encoding dystrophin, a 427 kDa scaffolding protein responsible for providing a mechanical link between the muscle fiber actin cytoskeleton and laminin in the extracellular matrix. The 7β1 integrin is a transmembrane linkage system in skeleta ...
STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Antioxidant enzyme-loaded Pro-NP for treatment of TBI.
SBC: ProTransit Nanotherapy, LLC Topic: 106ABSTRACT Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide and comes with a significant economic burden associated with emergency room visits and hospitalizations. Oxidative stress- mediated secondary injury post-TBI is a considerable risk factor for mortality and long-term impairment. Immediately following TBI, a cascade of biological responses leads to i ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
An Economical Point-of-Care Software Solution Prototype for Medication Prior Authorization
SBC: Breezmed Topic: 104ABSTRACT This STTR Phase I project uses mixed-method formative evaluation strategies to develop, test, and evaluate an alpha prototype of Breezmed, a point-of-care electronic prior authorization web-based platform. Prior authorization burdens the current medical system, hampering a provider’s ability to efficiently prescribe medication and in a timely fashion. This often leads to treatment non-c ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
Improving treatment options and outcomes in fungal keratitis
SBC: TranZ Biosciences LLC Topic: NABSTRACT Fungal keratitisprimarily caused by CandidaFusariumor Aspergillus speciesis a leading cause of blindness among corneal diseasesAmphotericin BAmBremains the gold standard in the treatment of Candida keratitis and is also the fallback option for other corneal fungal infectionsAlthough widely used off label in ocular infectionsophthalmic AmB formulations are not available commerciallyThe com ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of a Process for GMP Production of Natural THC and CBD
SBC: ElSohly Laboratories, Incorporated Topic: R41Development Process for Production of Natural THC and CBD AbstractTetrahydrocannabinolTHCand cannabidiolCBDare two major constituents of the cannabis plant that have pharmacological properties with potential therapeutic value in several disease conditionsWhileTHC has already been in use clinically for two indicationsnausea and vomiting in cancer patients receiving chemotherapy and appetite stimula ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of a lead cyclic-PDZ-Enhancer drug for Anxiety and Depression
SBC: Aingeal, LLC Topic: 101Major depressive disorder is a debilitating mood disorder that affects ~7% of US adults in their lifetime, costing the U.S. economy more than $200 billion a year. Drugs that increase monoaminergic signaling are the mainstay of depression therapy, but have a delayed onset of action and are only effective in about 50% of affected patients. Aberrant brain-derived neurotrophic factor (BDNF) signaling ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of a Personalized Bioreactor for Cell Culturing in Alginate Tubes
SBC: CellGro Technologies, LLC Topic: 400PROJECT SUMMARY ABSTRACT SignificanceCell therapy is expected to become an important method to treat chronic diseases such as diabetesrheumatoid arthritisretinal diseases like macular degeneration and certain types of cancersThe cell therapy market in general is projected to become a $billion industry byHuman pluripotent stem cellshPSCsare of particular importance since their utility as a source f ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Targeted Therapy for Myasthenia Gravis
SBC: ARC Biotechnology LLC Topic: NINDSMyasthenia gravis is a severe neuromuscular disease primarily caused by complement activating autoantibodies directed towards the skeletal muscle acetylcholine receptor. Present treatments are ineffectiveand uniformly have adverse effects, which negatively impact quality of life. Despite being a rare disease, myasthenia gravis is a costly one with a hospitalization expense of half a billion dollar ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Novel High-Resolution Scintillation X-ray Detectors for Digital Dentistry
SBC: NGS Detectors LLC Topic: NIDCRProject SummaryNovel High Resolution Scintillation X ray Detectors for Digital Dentistry The transition from traditional film to digital X ray detectors has resulted in significant improvements across many areas for dental X ray imaging ranging from decreased wait timesimproved logistics and even lower radiation dose ratesOne significant drawback remains with digital X ray imaging howeverwhich is ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health